{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:44:45Z","timestamp":1792629885581,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7931","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,10,13]]},"DOI":"10.1038\/s41586-022-05282-z","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:02:59Z","timestamp":1664971379000},"page":"381-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry"],"prefix":"10.1038","volume":"610","author":[{"given":"John","family":"Kee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6670-3970","authenticated-orcid":false,"given":"Samuel","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0548-3876","authenticated-orcid":false,"given":"David M.","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Glastad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Palozola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1721-741X","authenticated-orcid":false,"given":"Yize","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-1422","authenticated-orcid":false,"given":"Joseph","family":"Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6656-2941","authenticated-orcid":false,"given":"Andrey","family":"Poleshko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8720-5062","authenticated-orcid":false,"given":"Anna A.","family":"Kiseleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Truitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian L.","family":"Cardenas-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-016X","authenticated-orcid":false,"given":"Xuping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-8476","authenticated-orcid":false,"given":"Darrell N.","family":"Kotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos D.","family":"Alysandratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-1616","authenticated-orcid":false,"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-2336","authenticated-orcid":false,"given":"Wenli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Morrisey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-4400","authenticated-orcid":false,"given":"Shelley L.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7064-8123","authenticated-orcid":false,"given":"Erica","family":"Korb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"5282_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"5282_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045 (2020).","journal-title":"Cell"},{"key":"5282_CR3","doi-asserted-by":"publisher","first-page":"e2022643118","DOI":"10.1073\/pnas.2022643118","volume":"118","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl Acad. Sci. USA 118, e2022643118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5282_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature10892","volume":"483","author":"I Marazzi","year":"2012","unstructured":"Marazzi, I. et al. Suppression of the antiviral response by an influenza histone mimic. Nature 483, 428\u2013433 (2012).","journal-title":"Nature"},{"key":"5282_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1101\/sqb.2013.78.020339","volume":"78","author":"U Schaefer","year":"2013","unstructured":"Schaefer, U., Ho, J. S. Y., Prinjha, R. K. & Tarakhovsky, A. The \u2018histone mimicry\u2019 by pathogens. Cold Spring Harb. Symp. Quant. Biol. 78, 81\u201390 (2013).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"5282_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature18317","volume":"535","author":"DC Avgousti","year":"2016","unstructured":"Avgousti, D. C. et al. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature 535, 173\u2013177 (2016).","journal-title":"Nature"},{"key":"5282_CR7","doi-asserted-by":"publisher","first-page":"e01089-17","DOI":"10.1128\/JVI.01089-17","volume":"91","author":"DC Avgousti","year":"2017","unstructured":"Avgousti, D. C. et al. Adenovirus core protein VII downregulates the DNA damage response on the host genome. J. Virol. 91, e01089-17 (2017).","journal-title":"J. Virol."},{"key":"5282_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.20180099","volume":"215","author":"A Tarakhovsky","year":"2018","unstructured":"Tarakhovsky, A. & Prinjha, R. K. Drawing on disorder: how viruses use histone mimicry to their advantage. J. Exp. Med. 215, 1777\u20131787 (2018).","journal-title":"J. Exp. Med."},{"key":"5282_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41\u201345 (2000).","journal-title":"Nature"},{"key":"5282_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","volume":"293","author":"T Jenuwein","year":"2001","unstructured":"Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074\u20131080 (2001).","journal-title":"Science"},{"key":"5282_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature05915","volume":"447","author":"SL Berger","year":"2007","unstructured":"Berger, S. L. The complex language of chromatin regulation during transcription. Nature 447, 407\u2013412 (2007).","journal-title":"Nature"},{"key":"5282_CR12","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.cell.2021.03.051","volume":"184","author":"JSY Ho","year":"2021","unstructured":"Ho, J. S. Y. et al. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell 184, 2618\u20132632 (2021).","journal-title":"Cell"},{"key":"5282_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03995-1","volume":"599","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 599, 283\u2013289 (2021).","journal-title":"Nature"},{"key":"5282_CR14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cell.2022.01.024","volume":"185","author":"M Zazhytska","year":"2022","unstructured":"Zazhytska, M. et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell 185, 1052\u20131064 (2022).","journal-title":"Cell"},{"key":"5282_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nrmicro2222","volume":"7","author":"NC Elde","year":"2009","unstructured":"Elde, N. C. & Malik, H. S. The evolutionary conundrum of pathogen mimicry. Nat. Rev. Microbiol. 7, 787\u2013797 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"5282_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tibs.2010.10.002","volume":"36","author":"NE Davey","year":"2011","unstructured":"Davey, N. E., Trav\u00e9, G. & Gibson, T. J. How viruses hijack cell regulation. Trends Biochem. Sci. 36, 159\u2013169 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"5282_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molcel.2012.02.004","volume":"46","author":"MS Chaurushiya","year":"2012","unstructured":"Chaurushiya, M. S. et al. Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain. Mol. Cell 46, 79\u201390 (2012).","journal-title":"Mol. Cell"},{"key":"5282_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF-W Chan","year":"2020","unstructured":"Chan, J. F.-W. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 9, 221\u2013236 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"5282_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565\u2013574 (2020).","journal-title":"Lancet"},{"key":"5282_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13578-020-00404-4","volume":"10","author":"K-S Yuen","year":"2020","unstructured":"Yuen, K.-S., Ye, Z.-W., Fung, S.-Y., Chan, C.-P. & Jin, D.-Y. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 10, 40 (2020).","journal-title":"Cell Biosci."},{"key":"5282_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.molcel.2007.06.026","volume":"27","author":"SC Sampath","year":"2007","unstructured":"Sampath, S. C. et al. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol. Cell 27, 596\u2013608 (2007).","journal-title":"Mol. Cell"},{"key":"5282_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"5282_CR23","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.str.2022.05.020","volume":"30","author":"KR Vann","year":"2022","unstructured":"Vann, K. R. et al. Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection. Structure 30, 1224\u20131232 (2022).","journal-title":"Structure"},{"key":"5282_CR24","doi-asserted-by":"crossref","unstructured":"Flower, T. G. et al. Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc. Natl Acad. Sci. USA 118, e2021785118 (2021).","DOI":"10.1073\/pnas.2021785118"},{"key":"5282_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33487-8","volume":"8","author":"D Muth","year":"2018","unstructured":"Muth, D. et al. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission. Sci. Rep. 8, 15177 (2018).","journal-title":"Sci. Rep."},{"key":"5282_CR26","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41590-020-0773-7","volume":"21","author":"A Hachim","year":"2020","unstructured":"Hachim, A. et al. ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat. Immunol. 21, 1293\u20131301 (2020).","journal-title":"Nat. Immunol."},{"key":"5282_CR27","doi-asserted-by":"publisher","first-page":"e02431-20","DOI":"10.1128\/mBio.02431-20","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Accurate diagnosis of COVID-19 by a novel immunogenic secreted SARS-CoV-2 orf8 protein. mBio 11, e02431-20 (2020).","journal-title":"mBio"},{"key":"5282_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469\u2013472 (2020).","journal-title":"Nature"},{"key":"5282_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","volume":"182","author":"M Bouhaddou","year":"2020","unstructured":"Bouhaddou, M. et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685\u2013712 (2020).","journal-title":"Cell"},{"key":"5282_CR30","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399. Proc. Natl Acad. Sci. USA 118, e2024202118 (2021).","DOI":"10.1073\/pnas.2024202118"},{"key":"5282_CR31","doi-asserted-by":"publisher","first-page":"703145","DOI":"10.3389\/fmicb.2021.703145","volume":"12","author":"F Rashid","year":"2021","unstructured":"Rashid, F. et al. Mutations in SARS-CoV-2 ORF8 altered the bonding network with interferon regulatory factor 3 to evade host immune system. Front. Microbiol. 12, 703145 (2021).","journal-title":"Front. Microbiol."},{"key":"5282_CR32","doi-asserted-by":"publisher","first-page":"198350","DOI":"10.1016\/j.virusres.2021.198350","volume":"296","author":"F Rashid","year":"2021","unstructured":"Rashid, F., Dzakah, E. E., Wang, H. & Tang, S. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon \u03b2. Virus Res. 296, 198350 (2021).","journal-title":"Virus Res."},{"key":"5282_CR33","doi-asserted-by":"publisher","first-page":"679482","DOI":"10.3389\/fimmu.2021.679482","volume":"12","author":"H Geng","year":"2021","unstructured":"Geng, H. et al. SARS-CoV-2 ORF8 forms intracellular aggregates and inhibits IFN\u03b3-induced antiviral gene expression in human lung epithelial cells. Front. Immunol. 12, 679482 (2021).","journal-title":"Front. Immunol."},{"key":"5282_CR34","doi-asserted-by":"publisher","first-page":"102293","DOI":"10.1016\/j.isci.2021.102293","volume":"24","author":"X Lin","year":"2021","unstructured":"Lin, X. et al. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. iScience 24, 102293 (2021).","journal-title":"iScience"},{"key":"5282_CR35","doi-asserted-by":"publisher","first-page":"e0040222","DOI":"10.1128\/mbio.00402-22","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Viral mimicry of interleukin-17A by SARS-CoV-2 ORF8. mBio 13, e0040222 (2022).","journal-title":"mBio"},{"key":"5282_CR36","doi-asserted-by":"publisher","first-page":"899546","DOI":"10.3389\/fcimb.2022.899546","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Severe acute respiratory syndrome coronavirus 2 ORF8 protein inhibits type I interferon production by targeting HSP90B1 signaling. Front. Cell. Infect. Microbiol. 12, 899546 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"5282_CR37","doi-asserted-by":"publisher","first-page":"198074","DOI":"10.1016\/j.virusres.2020.198074","volume":"286","author":"J-Y Li","year":"2020","unstructured":"Li, J.-Y. et al. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res. 286, 198074 (2020).","journal-title":"Virus Res."},{"key":"5282_CR38","doi-asserted-by":"publisher","first-page":"101724","DOI":"10.1016\/j.jbc.2022.101724","volume":"298","author":"K Matsuoka","year":"2022","unstructured":"Matsuoka, K. et al. SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer. J. Biol. Chem. 298, 101724 (2022).","journal-title":"J. Biol. Chem."},{"key":"5282_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbrc.2021.05.074","volume":"563","author":"S Ohki","year":"2021","unstructured":"Ohki, S., Imamura, T., Higashimura, Y., Matsumoto, K. & Mori, M. Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant. Biochem. Biophys. Res. Commun. 563, 92\u201397 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5282_CR40","doi-asserted-by":"publisher","unstructured":"Zinzula, L. Lost in deletion: the enigmatic ORF8 protein of SARS-CoV-2. Biochem. Biophys. Res. Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2020.10.045 (2020).","DOI":"10.1016\/j.bbrc.2020.10.045"},{"key":"5282_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie, X. et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27, 841\u2013848 (2020).","journal-title":"Cell Host Microbe"},{"key":"5282_CR42","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41596-021-00491-8","volume":"16","author":"X Xie","year":"2021","unstructured":"Xie, X. et al. Engineering SARS-CoV-2 using a reverse genetic system. Nat. Protoc. 16, 1761\u20131784 (2021).","journal-title":"Nat. Protoc."},{"key":"5282_CR43","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl Acad. Sci. USA 118, e2022643118 (2021).","DOI":"10.1073\/pnas.2022643118"},{"key":"5282_CR44","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41596-019-0220-0","volume":"14","author":"A Jacob","year":"2019","unstructured":"Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303\u20133332 (2019).","journal-title":"Nat. Protoc."},{"key":"5282_CR45","doi-asserted-by":"publisher","unstructured":"Wang, R. et al. SARS-CoV-2 restructures the host chromatin architecture. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.07.20.453146 (2021).","DOI":"10.1101\/2021.07.20.453146"},{"key":"5282_CR46","doi-asserted-by":"publisher","first-page":"693227","DOI":"10.3389\/fgene.2021.693227","volume":"12","author":"A Valcarcel","year":"2021","unstructured":"Valcarcel, A., Bensussen, A., \u00c1lvarez-Buylla, E. R. & D\u00edaz, J. Structural analysis of SARS-CoV-2 ORF8 protein: pathogenic and therapeutic implications. Front. Genet. 12, 693227 (2021).","journal-title":"Front. Genet."},{"key":"5282_CR47","doi-asserted-by":"publisher","first-page":"e0040221","DOI":"10.1128\/JVI.00402-21","volume":"95","author":"JA Silvas","year":"2021","unstructured":"Silvas, J. A. et al. Contribution of SARS-CoV-2 accessory proteins to viral pathogenicity in K18 human ACE2 transgenic mice. J. Virol. 95, e0040221 (2021).","journal-title":"J. Virol."},{"key":"5282_CR48","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(20)31757-8","volume":"396","author":"BE Young","year":"2020","unstructured":"Young, B. E. et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet 396, 603\u2013611 (2020).","journal-title":"Lancet"},{"key":"5282_CR49","doi-asserted-by":"publisher","unstructured":"Fong, S.-W. et al. Robust virus-specific adaptive immunity in COVID-19 patients with SARS-CoV-2 \u0394382 variant infection. J. Clin. Immunol. https:\/\/doi.org\/10.1007\/s10875-021-01142-z (2021).","DOI":"10.1007\/s10875-021-01142-z"},{"key":"5282_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08780-2","volume":"12","author":"S DeRonde","year":"2022","unstructured":"DeRonde, S., Deuling, H., Parker, J. & Chen, J. Identification of a novel SARS-CoV-2 variant with a truncated protein in ORF8 gene by next generation sequencing. Sci. Rep. 12, 4631 (2022).","journal-title":"Sci. Rep."},{"key":"5282_CR51","doi-asserted-by":"publisher","unstructured":"Porter, E. G., Connelly, K. E. & Dykhuizen, E. C. Sequential salt extractions for the analysis of bulk chromatin binding properties of chromatin modifying complexes. J. Vis. Exp. https:\/\/doi.org\/10.3791\/55369 (2017).","DOI":"10.3791\/55369"},{"key":"5282_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"5282_CR53","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"5282_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"5282_CR55","doi-asserted-by":"publisher","unstructured":"Stark, R. & Brown, G. DiffBind https:\/\/doi.org\/10.18129\/B9.BIOC.DIFFBIND (2017).","DOI":"10.18129\/B9.BIOC.DIFFBIND"},{"key":"5282_CR56","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"5282_CR57","doi-asserted-by":"publisher","unstructured":"Sidoli, S., Bhanu, N. V., Karch, K. R., Wang, X. & Garcia, B. A. Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. J. Vis. Exp. https:\/\/doi.org\/10.3791\/54112 (2016).","DOI":"10.3791\/54112"},{"key":"5282_CR58","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1074\/mcp.O113.036459","volume":"13","author":"S Lin","year":"2014","unstructured":"Lin, S. et al. Stable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometry. Mol. Cell. Proteomics 13, 2450\u20132466 (2014).","journal-title":"Mol. Cell. Proteomics"},{"key":"5282_CR59","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","volume":"11","author":"AC Peterson","year":"2012","unstructured":"Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S. & Coon, J. J. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11, 1475\u20131488 (2012).","journal-title":"Mol. Cell. Proteomics"},{"key":"5282_CR60","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean, B. et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26, 966\u2013968 (2010).","journal-title":"Bioinformatics"},{"key":"5282_CR61","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1074\/mcp.TIR118.001209","volume":"18","author":"DR Brademan","year":"2019","unstructured":"Brademan, D. R., Riley, N. M., Kwiecien, N. W. & Coon, J. J. Interactive Peptide Spectral Annotator: a versatile web-based tool for proteomic applications. Mol. Cell. Proteomics 18, S193\u2013S201 (2019).","journal-title":"Mol. Cell. Proteomics"},{"key":"5282_CR62","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1038\/s41586-022-05631-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000}},{"DOI":"10.1038\/s41586-023-05764-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05282-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05282-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T12:17:34Z","timestamp":1675858654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05282-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":62,"journal-issue":{"issue":"7931","published-print":{"date-parts":[[2022,10,13]]}},"alternative-id":["5282"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05282-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-137433\/v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.742353001.793596576","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.742353001.793595937","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-023-05764-8","URL":"https:\/\/doi.org\/10.1038\/s41586-023-05764-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-022-05631-y","URL":"https:\/\/doi.org\/10.1038\/s41586-022-05631-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The laboratory of P.-Y.S. has received funding support in sponsored research agreements from Pfizer, Gilead, Novartis, Merck, GSK, IGM Biosciences and Atea Pharmaceuticals. P.-Y.S. is a member of the scientific advisory boards of AbImmune and is founder of FlaviTech. S.R.W. is on the scientific advisory board of Ocugen and Immunome.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}